« Conclusion: Our results support early use of rIFN-a as a safe, disease-modifying treatment of rigorously defined PV to delay and potentially prevent Post PV myelofibrosis, and prolong overall survival of PV pts »
Interferon in Polycythemia Vera (PV) Yields Impr... - MPN Voice
Interferon in Polycythemia Vera (PV) Yields Improved Myelofibrosis-Free and Overall Survival
Written by
Manouche
To view profiles and participate in discussions please or .
Read more about...
1 Reply
•
This is good to know. If only it wasn't so expensive.
Not what you're looking for?
You may also like...
Interferon-Alpha Reduces Myelofibrosis Risk, Mortality Rate in Low- and High-Risk Polycythemia Vera
phlebotomy-only group.
The rate of myelofibrosis-free survival (MFS) of high-risk patients was...
ASH 2019 | Ropeg in polycythemia vera: long-term PROUD-PV and CONTI-PV results
https://www.vjhemonc.com/video/elvsbiyxlco-ropeg-in-polycythemia-vera-long-term-proud-pv-and-conti-p
Event-free survival in patients with polycythemia vera treated with Besremi versus best available treatment
center [3]. Although overall survival was not evaluated, our findings lend support to this view,...
Polycythemia Vera (PV): Update on Emerging Treatment Options
that has shown the most encouraging results is givinostat. »...
Related Posts
New Study: Predicted Survival in Polycythemia Vera Patients- Phase 3, Trial of Interferon-α versus Hydroxyurea in Polycythemia Vera and Essential Thrombocythemia
- Statin use, survival and incidence of thrombosis among older patients with polycythemia vera and essential thrombocythemia
A randomized phase 3 trial of interferon-α vs hydroxyurea in polycythemia vera and essential thrombocythemia- BESREMI ACHIEVES PATIENT-SPECIFIC TREATMENT GOALS IN POLYCYTHEMIA VERA: FINAL RESULTS FROM THE PROUD-PV/CONTINUATION-PV STUDIES
